Clinical Trial: Safety & Efficacy of Qurs E Fishar in Mild to Moderate Hypertensive Patients in Pakistan

U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852079) titled 'Safety & Efficacy of Qurs E Fishar in Mild to Moderate Hypertensive Patients in Pakistan' on Feb. 24.

Brief Summary: The herbal medicine Qurs-e-Fishar to treat mild to moderate High blood pressure or hypertension comprises of Rauwolfia serpentina. A product of Hamdard Laboratories (Waqf) Pakistan.

A Phase III Safety & Efficacy Open-label, Single-Arm, Interventional, Multicenter, Study in mild to moderate hypertensive, adults (30 to 60 years of age) prescribed with study product for 12 weeks (84 days).

Primary End Points:

1. Reduction in diastolic blood pressure less than 130 / 80 mmHg at the end of the study period (accepted by W...